ARZNEIMITTEL UND DEREN VERWENDUNG

Patent europeic · EP1059941 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1059941
Numer da la dumonda
EP99909085
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
05-03-1999
Publitgà
20-12-2000
Concedì
26-05-2004
Stritgà
31-03-2009
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 47/24 (2006.01)
A61K 9/48 (2006.01)
Prioritad
GB 9804705 05.03.1998
GB 9827835 17.12.1998
Dumonda PCT
PCT/GB1999/000656 05.03.1999
Publicaziun PCT
WO1999/044642 10.09.1999
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-10-2009

    Stritgà, taxa betg pajada

    Published in Swissreg on 21.10.2009

  2. 30-07-2004

    Represchentant inscrit

    Representative
    Riederer Hasler & Partner Patentanwälte AG, Kappelestrasse 15, 9492 Eschen, Liechtenstein

    Published in +pat+ No 14 in 2004

  3. 30-07-2004

    Adressa midada

    Owner
    PHARES PHARMACEUTICAL RESEARCH N.V., 14 John B. Gorsiraweg,, P.O. Box 3889, Curacao, Netherlands Antilles, Netherlands Antilles → PHARES PHARMACEUTICAL RESEARCH N.V., P.O. Box 6052,, Emancipatie Boulevard 31, Curacao,, Netherlands Antilles, Netherlands Antilles

    Published in +pat+ No 14 in 2004

  4. 28-05-2004

    Concedì

    Published in +pat+ No 10 in 2004

Partidas

Inventur

LEIGH, Steven

Warlingham, Surrey CR6 9HJ, GB

LEIGH, Mathew Louis Steven

Warlingham, Surrey CR6 9HJ, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.